Effect of depression care on outcomes in COPD patients with depression

Chest

Volumn 135, Issue 3, 2009, Pages 626-632

  Jordan, Neil ^a,c   Lee, Todd A ^a   Valenstein, Marcia ^a   Pirraglia, Paul A ^a   Weiss, Kevin B ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

COPD; Depression; Evidence based treatment; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION;

EID: 62149132144     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-0839     Document Type: Article

References (27)

1. Clary GL, Palmer SM, Doraiswamy PM. Mood disorders and chronic obstructive pulmonary disease: current research and future needs. Curr Psychiatry Rep 2002; 4:213-221
2. Mikkelsen RL, Middelboe T, Pisinger C, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD): a review. Nord J Psychiatry 2004; 58:65-70
3. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD 2005; 2:185-193
4. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122:1633-1637
5. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res 1997; 46:26-31
6. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41:465-471
7. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167:60-67
8. Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001; 23:56-61
9. Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47:312-319
10. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34:491-496
11. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448
12. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Database Syst Rev (database online). Issue 4, 2006
13. Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med 2005; 35:271-279
14. Borson S, Mcdonald GJ, Gayle T, et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary-disease. Psychosomatics 1992; 33:190-201
15. Lacasse Y, Beaudoin L, Rousseau L, et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004; 61:140-147
16. Eiser N, Harte R, Spiros K, et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005; 2:233-241
17. Light RW, Merrill EJ, Despars J, et al. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 1986; 146:1377-1380
18. Silvertooth EJ, Doraiswamy PM, Clary GL, et al. Citalopram and quality of life in lung transplant recipients. Psychosomatics 2004; 45:271-272
19. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med 2007; 147:320-329
20. Charbonneau A, Rosen AK, Owen RR, et al. Monitoring depression care: in search of an accurate quality indicator. Med Care 2004; 42:522-531
21. Katon W, Cantrell CR, Sokol MC, et al. Impact of antidepressant on comorbid medication drug adherence use and resource utilization. Arch Intern Med 2005; 165:2497-2503
22. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001; 16:451-454
23. Pirraglia PA, Charbonneau A, Kader B, et al. Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans. Prim Care Companion. J Clin Psychiatry 2006; 8:71-76
24. Jordan N, Lee TA, Valenstein M, et al. Effect of care setting on evidence-based depression treatment for veterans with COPD and co-morbid depression. J Gen Intern Med 2007; 22:1447-1452
25. Chermack ST, Wryobeck JM, Austin KL, et al. The delivery of psychotherapy and medication management services to depressed patients in the VA. Available at: http://www.hsrd.research.va.gov/meetings/2005/display-abstract.cfm?RecordID= 84. Accessed October 28, 2008
26. Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001; 31:717-723
27. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003; 84:1154-1157